Hematogenix

Hematogenix, a global cancer-focused life science company serving the pharmaceutical & biotechnology industry as well as community physicians. With passionate scientists and board-certified clinical and anatomic pathologists and hematopathologists from around the world, Hematogenix offers an array of biomarker development and testing services navigating the complexities of human diseases and clinical trials. Our global team of scientists provides reference laboratory services at our facilities around the globe: in the US, Europe, China, and Asia-Pacific. We are uniquely equipped to help clients accelerate cancer research and drug development efforts at these globally connected facilities. Hematogenix provides a complete menu of services...

Oncology,hematopathology,pharma services,ihc,flow cytometry,next generation sequencing,digital pathology,image analysis,molecular genetics,cytogenetics,histology,immunohistochemistry (ihc),fish,pathology,cap – accredited,clia – certified,and gcp – compliant

Hematogenix operates in the Hospitals and health care industry.

Hematogenix's revenue is 11m - 100m

Hematogenix has 51 - 200 employees.